These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 480377)

  • 1. Rapid in vivo assay of mouse natural killer cell activity.
    Riccardi C; Puccetti P; Santoni A; Herberman RB
    J Natl Cancer Inst; 1979 Oct; 63(4):1041-5. PubMed ID: 480377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic administration of recombinant interleukin-6 in mice induces proliferation of lymphoid cells in vivo.
    Puri RK; Leland P
    Lymphokine Cytokine Res; 1992 Jun; 11(3):133-9. PubMed ID: 1391232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vivo lysis of tumor cells of varying degrees of immune resistance].
    Viksler VKh; Ustinov AS
    Eksp Onkol; 1989; 11(3):55-60. PubMed ID: 2752945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural killer cells in mouse lung: surface phenotype, target preference, and response to local influenza virus infection.
    Stein-Streilein J; Bennett M; Mann D; Kumar V
    J Immunol; 1983 Dec; 131(6):2699-704. PubMed ID: 6644021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between natural reactivity (NR) against Candida albicans and natural killer (NK) activity against YAC-1 tumour cells.
    Bistoni F; Baccarini M; Blasi E; Riccardi C; Favalli C
    Int J Tissue React; 1983; 5(1):73-84. PubMed ID: 6345429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demonstration of natural antibodies in normal rabbit serum with similar specificity pattern as mouse natural killer cells.
    Grönberg A; Hansson M; Kiessling R; Andersson B; Kärre K; Roder J
    J Natl Cancer Inst; 1980 May; 64(5):1113-9. PubMed ID: 6966004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility of various strains of mice to urethan-induced lung tumors and depressed natural killer cell activity.
    Gorelik E; Herberman RB
    J Natl Cancer Inst; 1981 Dec; 67(6):1317-22. PubMed ID: 6947114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the activity of mouse natural killer cells by urethan.
    Gorelik E; Herberman RB
    J Natl Cancer Inst; 1981 Mar; 66(3):543-8. PubMed ID: 6937709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in resistance of metastatic tumor cells and cells from local tumor growth to cytotoxicity of natural killer cells.
    Gorelik E; Fogel M; Feldman M; Segal S
    J Natl Cancer Inst; 1979 Dec; 63(6):1397-404. PubMed ID: 292811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural cytotoxicity against mouse hepatitis virus-infected target cells. I. Correlation of cytotoxicity with virus binding to leukocytes.
    Holmes KV; Welsh RM; Haspel MV
    J Immunol; 1986 Feb; 136(4):1446-53. PubMed ID: 3003198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of mouse natural killer activity by cyclosporin A.
    Yanagihara RH; Adler WH
    Immunology; 1982 Feb; 45(2):325-32. PubMed ID: 6460686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of in vivo generation of cytotoxic effector cells against tumor in tumor-bearing mice.
    Fuyama S; Yamamoto H; Fujii Y; Arai S
    Cancer Res; 1986 Nov; 46(11):5548-52. PubMed ID: 2428480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo interaction between murine fibrosarcoma cells and natural killer cells.
    Laybourn KA; Hiserodt JC; Abruzzo LV; Varani J
    Cancer Res; 1986 Jul; 46(7):3407-12. PubMed ID: 2939945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Splenocyte natural killer cell activity and metastatic potential are inversely dependent on estrous stage.
    Gruber SA; Hoffman RA; Sothern RB; Lakatua D; Carlson A; Simmons RL; Hrushesky WJ
    Surgery; 1988 Aug; 104(2):398-403. PubMed ID: 3261050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of correlation between natural killer activity and tumor growth control in nude mice with different immune defects.
    Fodstad O; Hansen CT; Cannon GB; Statham CN; Lichtenstein GR; Boyd MR
    Cancer Res; 1984 Oct; 44(10):4403-8. PubMed ID: 6467201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of murine non-specific killer cells induced in vivo by recombinant human interleukin-2.
    Hinuma S; Naruo K; Shiho O; Tsukamoto K
    Immunology; 1986 Oct; 59(2):251-9. PubMed ID: 3490435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural immunity to grafts of FLD-3 erythroleukemia cells by irradiated mice.
    Afifi MS; Bennett M; Kumar V
    Nat Immun Cell Growth Regul; 1986; 5(4):200-10. PubMed ID: 2430178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antileukemia activity of a natural killer cell line against human leukemias.
    Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
    Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient appearance of hepatic natural killer cells with high cytotoxicity and unique phenotype in very young mice.
    Bai X; Wang S; Tomiyama-Miyaji C; Shen J; Taniguchi T; Izumi N; Li C; Bakir HY; Nagura T; Takahashi S; Kawamura T; Iiai T; Okamoto H; Hatakeyama K; Abo T
    Scand J Immunol; 2006 Apr; 63(4):275-81. PubMed ID: 16623927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Murine strain variation in the natural killer cell and proliferative responses to the immunostimulatory compound 7-allyl-8-oxoguanosine: role of cytokines.
    Pope BL; Chourmouzis E; MacIntyre JP; Lee S; Goodman MG
    Cell Immunol; 1994 Dec; 159(2):194-210. PubMed ID: 7994754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.